Items where Subject is "RC254 Neoplasms. Tumors. Oncology"

2016

1. Machado, L., Moseley, P. M., Moss, R., Deen, S., Nolan, C., Spendlove, I., Ramage, J., Chan, S. and Durrant, L. G. (2016) Downregulation of the citrullinating enzyme Peptidyl-arginine deiminase type-2 in ovarian cancer indicates poor prognosis. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 06-09 November 2016.

2015

1. Durrant, L. G., Ottensmeier, C. H., Mulatero, C., Lorigan, P., Plummer , R., Cunnell, M., Metheringham, R., Brentville, V., Machado, L., Daniels , I., Hannaman, D. and Patel, P. M. (2015) A clinical trial of a DNA vaccine (SCIB1) that targets dendritic cells in vivo in fully resected melanoma patients; a vaccine to prevent disease recurrence? Poster presented to: 15th International Conference on Progress in Vaccination Against Cancer (PIVAC-15), Tübingen, Germany, 06-08 October 2015.
2. Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Hannaman, D., Cunnell, M., Metheringham, R. L., Brentville, V. A., Daniels, I., Machado, L. and Durrant, L. G. (2015) Abstract 9035: An adjuvant clinical trial of SCIB1, a DNA vaccine that targets dendritic cells in vivo, in fully resected melanoma patients. Journal of Clinical Oncology. 33(15 Sup) 0732-183X.
3. Zheng, Y., Parsonage, G., Zhuang, X., Machado, L., James, C., Salman, A., Searle, P., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2015) Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma. Cancer Immunology Research. 3(10), pp. 1138-1147. 2326-6066.

2014

1. Durrant, L. G., Ottensmeier, C., Lorigan, P., Mulatero, C., Plummer, R., Cunell, M., Metheringham, R. L., Brentville, V. A. and Machado, L. (2014) Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma. Cancer Research. 74(19 Sup) 0008-5472.
2. Durrant, L. G., Xue, L., Machado, L., Metheringham, R. L. and Brentville, V. A. (2014) DNA vaccines. In: Rees, R. C. (ed.) Tumor Immunology and Immunotherapy. Oxford: Oxford University Press. pp. 251-264.
3. Ekberg, M. E., Callender, M., Hamer, H. and Rogers, S. (2014) Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme. European Journal of Cancer Prevention. 23(5), pp. 391-397. 0959-8278.
4. Groves-Kirkby, C. J., Timson, K., Shield, G., Denman, A. R., Rogers, S., Campbell, J., Phillips, P. S. and Ekberg, M. E. (2014) Influences motivating smokers in a radon-affected area to quit smoking. Perspectives in Public Health. 134(1), pp. 44-56. 1757-9139.
5. Hargreaves, C., Iriyama, C., Rose-Zerilli, M., Lee, C., Potter, K., Ganderton, R., Hussain, K., Machado, L., Hollox, E. J., Coupland, S., Stackpole, M., Oates, M., Pettitt, A. R., Cragg, M. and Strefford, J. (2014) Genomic dissection of the Fcγ receptor region in the context of monoclonal antibody therapy. Blood. 124(21), p. 2996. 0006-4971.
6. Machado, L., Moseley, P., Moss, R., Nolan, C., Rampage, J., Chan, S. and Durrant, L. G. (2014) High-mobility group protein 1 (HMGB1) is an independent predictor of poor survival in ovarian cancer. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 02-05 November 2014. Also presented at: British Society for Immunology Annual Congress (BSI2014), Brighton, UK, 01-04 December 2014 (Unpublished)
7. Patel, P. M., Durrant, L. G., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I. and Hannaman, D. (2014) Phase I trial of ImmunoBody in melanoma patients. Poster presented to: 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, McCormick Place, Chicago, Illinois, 30 May - 03 June 2014. (Unpublished)

2013

1. Campbell, J. (2013) Increasing early detection of lung cancer. Invited Presentation presented to: Government Conference, Royal College of Surgeons, London, 28 November 2013. (Unpublished)

2012

1. Campbell, J., Rogers, S., Pyer, M. and Reddy, R. (2012) The early lung cancer detection initiative in Corby, Northamptonshire, UK. International Journal of Tuberculosis and Lung Disease. 16 (12)(Supp 1), S414. 1027-3719.
2. Campbell, J., Rogers, S., Pyer, M. and Reddy, R. (2012) The early lung cancer detection initiative in Corby, Northamptonshire, UK. Poster presented to: 43rd Union World Conference on Lung Health, of the International Union Against Tuberculosis and Lung Disease, Kuala Lumpur, Malaysia, 13-17 November 2012. (Unpublished)
3. Parsonage, G., Machado, L., Hui, J. W.-Y., McLarnon, A., Schmaler, T., Balasothy, M., To, K.-F., Vlantis, A. C., Hasselt, C. A. V., Lo, K.-W., Wong, W.-L., Hui, E. P., Cheung Chan, A. T. and Lee, S. P. (2012) CXCR6 and CCR5 localize T lymphocyte subsets in nasopharyngeal carcinoma. American Journal of Pathology. 180(3), pp. 1215-1222. 0002-9440.

2011

1. Groves-Kirkby, C. J., Timson, K., Shield, G., Denman, A. R., Rogers, S. and Phillips, P. S. (2011) Lung cancer reduction from smoking cessation and radon remediation: a preliminary cost analysis in Northamptonshire, UK. Environment International. 37(2), pp. 375-382. 0160-4120.
2. Owton, H. (2011) Granny’s memoirs. Qualitative Inquiry. 17(5), pp. 459-460. 1077-8004.

2010

1. Denman, A. R., Phillips, P. S., Groves-Kirkby, C. J., Timson, K., Shield, G., Rogers, S. and Campbell, J. (2010) Reducing lung cancer incidence by health campaigns : a review of the uptake, health benefits and cost effectiveness of smoking cessation and radon remediation programmes in Northamptonshire, UK. In: Proceedings of Third European IRPA Congress 2010 June 14-16, Helsinki, Finland.
2. Parsonage, G., Machado, L., Hui, J. W.-Y., Schmaler, T. T., Balasothy, M., Van Hasselt, A., Vlantis, L., Hui, E. P., Chan, A. T. C., Lo, K.-W. and Lee, S. P. (2010) T cell homing to nasopharyngeal carcinoma. Poster presented to: 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, University of Birmingham, 04-07 September 2010. (Unpublished)
3. Singlehurst, H., Corr, S., Wilson, J. M. and Allen, S. (2010) Using autobiography to explore occupational transitions of those living with or beyond cancer. Paper presented to: World Federation of Occupational Therapists (WFOT) 15th World Congress, Santiago, Chile, 04-07 May 2010. (Unpublished)
4. Zheng, Y., Machado, L., Johnson, B., James, C., Parsonage, G. and Lee, S. P. (2010) EBV-specific T cell receptor gene transfer to target nasopharyngeal carcinoma. Poster presented to: 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, University of Birmingham, 04-07 September 2010. (Unpublished)

2009

1. Boulter, L. and Beaulieu, K. (2009) Can professionals ease the burden faced by carers of cancer sufferers? Paper presented to: College of Occupational Therapists 33rd Annual Conference and Exhibition, Brighton, 23-26 June 2009. (Unpublished)
2. Denman, A. R., Phillips, P. S., Coskeran, T., Groves-Kirkby, C. J., Crockett, R. G. M. and Tornberg, R. (2009) Carefully targeted radon reduction strategies are more appropriate (rapid response to Gray et al.). British Medical Journal. 338 0959-8138.
3. Denman, A. R., Timson, K., Shield, G., Groves-Kirkby, C. J., Rogers, S., Campbell, J. and Phillips, P. S. (2009) Local health campaigns to reduce lung cancers induced by radon and smoking - who responds? Health Policy. 93(2), pp. 201-206. 0168-8510.
4. Denman, A. R., Timson, K., Shield, G., Groves-Kirkby, C. J., Rogers, S., Campbell, J. and Phillips, P. S. (2009) Local health campaigns to reduce lung cancers induced by radon and smoking – who responds? Invited Presentation presented to: Detecting the Evidence, Northampton, 02 April 2009. (Unpublished)
5. Machado, L., Jarrett, R., Morgan, S., Murray, P., Hunter, B., Hamilton, E., Crocker, J., Thomas, W., Steven, N., Ismail, T., Chapman, A., Adams, D. H. and Lee, S. P. (2009) Expression and function of T cell homing molecules in Hodkins's lymphoma. Cancer Immunology, Immunotherapy. 58(1), pp. 85-94. 0340-7004.
6. Russell, L., Capasso, M., Vater, I., Akasaka, T., Bernard, O., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., Guttery, D., Haferlach, C., Harder, L., Heidenreich, O., Irving, J., Kearney, L., Nguyen-Khac, F., Machado, L., Minto, L., Majid, A., Moorman, A., Morrison, H., Rand, V., Strefford, J., Schwab, C., Tonnies, H., Dyer, M., Siebert, R. and Harrison, C. (2009) Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 114(13), pp. 2688-2698. 0006-4971.
7. Walach, H. (2009) Mindfulness based approaches to oncology. Workshop presented to: Integrative Onkologie und Forschung, St Gallen, Switzerland, 30-31 October 2009. (Unpublished)
8. Walach, H. (2009) Classical homeopathic treatment of tumor patients - a comparative cohort study. Alternative Therapies in Health and Medicine. 15(3), 128-129 and 152. 1078-6791.
9. Walach, H., Guethlin, H., Naumann, J. and Rostock, M. (2009) Classical homeopathic treatment of tumour patients: a comparative cohort study. Poster presented to: North American Research Conference on Complementary & Integrative Medicine, Minneapolis, Minnesota, USA, 12-15 May 2009. (Unpublished)
10. Zheng, Y., Machado, L., Johnson, B., James, C., Parsonage, G. and Lee, S. P. (2009) T cell receptor gene transfer to target the Epstein-Barr virus-associated malignancy nasopharyngeal carcinoma. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, University of Birmingham, UK, 05-07 October 2009. (Unpublished)

2008

1. Baumforth, K. R. N., Birgersdotter, A., Reynolds, G. M., Wei, W., Kapatai, G., Flavell, J., Kalk, E., Piper, K., Lee, S. P., Machado, L., Hadley, K., Sundblad, A., Sjoberg, J., Bjorkholm, M., Porwit, A., Yap, L.-F., Teo, S., Grundy, R., Young, L. S., Ernberg, I., Woodman, C. and Murray, P. (2008) Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's Lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. The American Journal of Pathology. 173(1), pp. 195-204. 0002-9440.
2. Denman, A. R., Coskeran, T., Phillips, P. S., Crockett, R. G. M., Tornberg, R. and Groves-Kirkby, C. J. (2008) Lowering the UK domestic radon Action Level to prevent more lung cancers - is it cost-effective? Journal of Radiological Protection. 28(1), pp. 61-71. 0952-4746.
3. Denman, A. R., Groves-Kirkby, C. J., Coskeran, T., Phillips, P. S., Crockett, R. G. M. and Tornberg, R. (2008) Lowering the UK domestic radon action level to reduce radiation-induced lung cancer in the general population - when and where is it cost effective? In: Abstracts of the 12th International Congress of the International Radiation Protection Association. p. 463.
4. Denman, A. R., Groves-Kirkby, C. J., Timson, K., Shield, G., Rogers, S. and Phillips, P. S. (2008) Smoking cessation programmes in radon affected areas: can they make a significant contribution to reducing radon-induced lung cancers? Poster presented to: Faculty of Public Health Annual Conference, Cardiff, 3-5 June 2008. (Unpublished)
5. Russell, L., Capasso, M., Vater, I., Moorman, A., Akasaka, T., Harder, L., Heidenreich, O., Machado, L., Gest, S., Strefford, J., Chandrasekaran, T., Tonnies, H., Majid, A., Bernard, O., Dyer, M., Siebert, R. and Harrison, C. (2008) IGH@ translocations involving the pseudoautosomal region 1 (PAR1) of both sex chromosomes deregulate the cytokine receptor-like factor 2 (CRLF2) gene in B cell precursor acute lymphoblastic leukemia (BCP-ALL). Paper presented to: 50th American Society of Hematology (ASH) Annual Meeting and Exposition, San Francisco, California, 06-09 December 2008. (Unpublished)

2007

1. Denman, A. R., Coskeran, T., Phillips, P. S., Crockett, R. G. M. and Tornberg, R. (2007) Lowering the domestic radon level to prevent more lung cancers - is it cost effective? Paper presented to: 5th Conference on Protection Against Radon at Home and at Work, Prague, Czech Republic, 9-15 September 2007. (Unpublished)
2. Denman, A. R., Groves-Kirkby, C. J., Timson, S., Shield, G., Rogers, S. and Phillips, P. S. (2007) Can smoking cessation programmes make a significant contribution to lung cancer reduction in radon affected areas? Poster presented to: 5th Conference on Protection Against Radon at Home and at Work, Prague, Czech Republic, 9-15 September 2007. (Unpublished)
3. Gϋthlin, C., Hinrichs, I., Walach, H. and Rostock, M. (2007) Homeopathic treatment in cancer patients – a retrospective data analysis. Paper presented to: International Congress on Complementary Medicine Research, Munich, Germany, 11-13 May 2007. (Unpublished)
4. Lynch, S. and Walach, H. (2007) Subjective effects of deep field relaxation, a form of spiritual healing, on cancer patients – a qualitative study. Paper presented to: International Congress on Complementary Medicine Research, Munich, Germany, 11-13 May 2007. (Unpublished)
5. Machado, L., Jarrett, R., Morgan, S., Murray, P., Hunter, B., Crocker, J., Thomas, W., Steven, N., Ismail, T., Chapman, A., Adams, D. and Lee, S. P. (2007) Molecular mechanisms for T cell recruitment to Hodgkin's lymphoma. Poster presented to: Keystone Symposia on Molecular and Cellular Biology: The Potent New Anti-Tumor Immunotherapies, Banff, Alberta, Canada, 28 March - 02 April 2007. (Unpublished)
6. Machado, L., Schmaler, T. T., Balasothy, M., Morgan, S., Larsen, M., Hislop, A., Murray, P., Mack, M., Adams, D., Van Hasselt, A., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2007) CXCR6 and CCR5 mediate recruitment of CD4 and CD8 T lymphocytes to nasopharyngeal carcinoma. Poster presented to: Cancer Research UK Midlands Regional Meeting, Birmingham, UK, April 2007. (Unpublished)
7. Walach, H. (2007) Spirituelle Therapieansätze – wissenschaftliche Beweisfϋhrung: eine Problematik. Paper presented to: Complementary Medicine meets Oncology Conference, Freiburg, Germany, 29-30 November 2007. (Unpublished)
8. Walach, H., Schwarzer, T., Boencke, A., Mϋller, S., Seiter, C. and Weis, J. (2007) Subjective effects of deep field relaxation, a form of spiritual healing, on cancer patients – a qualitative study. Paper presented to: International Congress on Complementary Medicine Research, Munich, Germany, 11-13 May 2007. (Unpublished)

2006

1. Coskeran, T., Denman, A. R., Phillips, P. S., Gillmore, G. K. and Tornberg, R. (2006) A new methodology for cost effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within Primary Care Trusts in Central England. Science of The Total Environment. 366(1), pp. 32-46. 0048-9697.
2. Hamilton, E., Machado, L., Reynolds, G. M., Taniere, P., Lee, S. P., Steven, N. and Ismail, T. (2006) Biomarkers of the immune response in primary colorectal cancer. Poster presented to: Annual Meeting of the British Society of Gastroenterology, Surgical Section in Association with the Association of Coloproctology (ACPGBI) and IBD Section Joint Symposium, Birmingham, UK, 20-23 March 2006. (Unpublished)

2005

1. Denman, A. R., Phillips, P. S., Tornberg, R. and Groves-Kirkby, C. J. (2005) Analysis of the individual health benefits accruing from a domestic radon remediation programme. Journal of Environmental Radioactivity. 79(1), pp. 7-23. 0265-931X.
2. Lee, S. P., Green, A. M., Machado, L., Patel, P., Thomas, W., Goodyear, O., Briggs, D., McDonald, D., Marsden, J. and Steven, N. (2005) Infusing advanced cancer patients with tumour antigen-specific CD4+ and CD8+ T cell clones. Poster presented to: Annual Congress of the British Society for Immunology, Harrogate, UK, 06-09 December 2005. (Unpublished)

2003

1. Denman, A. R., Eatough, J. P., Gillmore, G. and Phillips, P. S. (2003) Assessment of health risks to skin and lung of elevated radon levels in abandoned mines. Health Physics. 85(6), pp. 733-740. 0017-9078.
2. Lee, S. P., Hewitt, A., Thomas, W., Machado, L., Goodyear, O., Marsden, J., Van der, B., Briggs, D. and Steven, N. (2003) Generating cancer/testis antigen- and Epstein-Barr virus-specific T cell clones for adoptive immunotherapy. Poster presented to: Keystone Symposia on Molecular and Cellular Biology: Basic Aspects of Tumour Immunology, Colorado, USA, 2003. (Unpublished)

2002

1. Denman, A. R., Phillips, P. S. and Tornberg, R. (2002) The costs and benefits of radon remediation programmes in existing homes: case study of action level selection. Journal of Environmental Radioactivity. 62(1), pp. 17-27. 0265-931X.
2. Kennedy, C. A., Gray, A. M., Denman, A. R. and Phillips, P. S. (2002) The cost-effectiveness of residential radon remediation programmes: assumptions about benefits stream profiles over time. Journal of Environmental Radioactivity. 59(1), pp. 19-28. 0265-931.

2000

1. Raleigh, S. M., Verschoyle, R. D., Bowskill, C., Pastorino, U., Staniforth, J. N., Steele, F., Dinsdale, D., Carthew, P., Lim, C. K., Silvester, J. and Gescher, A. (2000) Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol. British Journal of Cancer. 83(7), pp. 935-940. 0007-0920.

1999

1. Kennedy, C. A., Gray, A. M., Denman, A. R. and Phillips, P. S. (1999) A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom. British Journal of Cancer. 81(7), pp. 1243-1247. 0007-0920.
2. Patterson, L. H., McKeown, S. R., Robson, T., Gallagher, R., Raleigh, S. M. and Orr, S. (1999) Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. Anti-Cancer Drug Design. 14(6), pp. 473-486. 0266-9536.
3. Raleigh, S. M., Wanogho, E., Burke, M. D. and Patterson, L. H. (1999) Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug. Xenobiotica. 29(11), pp. 1115-1122. 0049-8254.

1998

1. Raleigh, S. M., Wanogho, E., Burke, M. D., McKeown, S. R. and Patterson, L. H. (1998) Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone di-N-oxide prodrug. International Journal of Radiation Oncology, Biology, Physics. 42(4), pp. 763-767. 0360-3016.

1997

1. Phillips, P. S. and Denman, A. R. (1997) Radon: a human carcinogen. Science Progress. 80(4), pp. 317-336. 0036-8504.